13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0001104659-23-090491
Total Value
$625.4M
Positions
30
Other Managers
0
Confidential Omitted
No
Holdings (30)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,082,622 | $73.3M | 11.73% |
| 2 | COGENT BIOSCIENCES INC | COGT | 4,684,132 | $55.5M | 8.87% |
| 3 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 3,000,000 | $54.2M | 8.67% |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 2,230,127 | $45.5M | 7.28% |
| 5 | MERUS N V | N5749R100 | 1,726,214 | $45.5M | 7.27% |
| 6 | GH RESEARCH PLC | GHRS | 3,517,125 | $41.7M | 6.67% |
| 7 | AMBRX BIOPHARMA INC | 02290A102 | 2,484,960 | $40.9M | 6.54% |
| 8 | KALVISTA PHARMACEUTICALS INC | KALV | 2,916,667 | $26.3M | 4.20% |
| 9 | TERNS PHARMACEUTICALS INC | TERN | 2,972,869 | $26.0M | 4.16% |
| 10 | CABALETTA BIO INC | CABA | 1,973,251 | $25.5M | 4.07% |
| 11 | DYNE THERAPEUTICS INC | DYN | 2,173,913 | $24.5M | 3.91% |
| 12 | CELCUITY INC | CELC | 2,105,386 | $23.1M | 3.70% |
| 13 | SAVARA INC | SVRA | 6,351,531 | $20.3M | 3.25% |
| 14 | PHARVARIS N V | PHVS | 1,326,200 | $20.1M | 3.21% |
| 15 | RHYTHM PHARMACEUTICALS INC | RYTM | 1,090,000 | $18.0M | 2.87% |
| 16 | ORIC PHARMACEUTICALS INC | ORIC | 2,142,856 | $16.6M | 2.66% |
| 17 | ACLARIS THERAPEUTICS INC | ACRS | 1,040,754 | $10.8M | 1.73% |
| 18 | TREVI THERAPEUTICS INC | TRVI | 3,422,397 | $8.2M | 1.31% |
| 19 | APPLIED THERAPEUTICS INC | 03828A101 | 5,658,034 | $7.2M | 1.16% |
| 20 | THESEUS PHARMACEUTICALS INC | 88369M101 | 770,000 | $7.2M | 1.15% |
| 21 | MILESTONE PHARMACEUTICALS IN | MIST | 2,208,812 | $6.3M | 1.01% |
| 22 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 3,886,246 | $6.2M | 0.99% |
| 23 | PRAXIS PRECISION MEDICINES I | PRAX | 5,304,410 | $6.1M | 0.98% |
| 24 | PLIANT THERAPEUTICS INC | PLRX | 288,949 | $5.2M | 0.84% |
| 25 | LYRA THERAPEUTICS INC | LYRA | 924,170 | $3.8M | 0.61% |
| 26 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 6,343,221 | $2.9M | 0.46% |
| 27 | BLACK DIAMOND THERAPEUTICS I | BDTX | 353,629 | $1.8M | 0.29% |
| 28 | RALLYBIO CORP | RLYB | 268,532 | $1.5M | 0.24% |
| 29 | AFFIMED N V | N01045108 | 1,428,571 | $854,571 | 0.14% |
| 30 | AVALO THERAPEUTICS INC | AVTX | 1,250,000 | $444,000 | 0.07% |